IP Library Granted Patent US 10,758,560
Granted Patent B2
US 10,758,560 · App. 15/778,791 · Granted Sep 1, 2020

Methods for treating sarcopenia and frailty

Inventors: Alice Pannerec (Lausanne, CH); Jerome Feige (Crissier, CH)
Assignee: Societe des Produits Nestle S.A.
A61K31/714A61K38/18A61K38/1883G01N33/5023G01N33/6893A61P43/00G01N2800/10G01N2800/50G01N2800/7042
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,758,560
App. No.
15/778,791
Granted
Sep 1, 2020
Kind
B2
Abstract

Neuregulin-1 (NRG1) or a fragment thereof or vitamin B12 for use in maintaining or increasing muscle function and/or mass in an ageing subject, and/or substantially preventing or reducing muscle wasting in an ageing subject.

Claims (6)

1. A method of maintaining or increasing muscle function and/or mass in an ageing subject over thirty years old, the method comprising administering neuregulin-1 (NRG1) comprising the amino acid sequence of SEQ. ID. NO. 6 to the ageing subject.

2. The method of claim 1 , wherein the method further comprises administering vitamin B12 to the ageing subject in need thereof.

3. The method of claim 2 , wherein the vitamin B12 comprises at least one of adenosylcobalamin or methylcobalamin.

4. A method of treating sarcopenia or frailty, the method comprising administering neuregulin-1 (NRG1) comprising the amino acid sequence of SEQ. ID. NO. 6 to a subject in need thereof.

5. The method of claim 4 , wherein the method further comprises administering vitamin B12 to the subject in need thereof.

6. The method of claim 5 , wherein the vitamin B12 is at least one of adenosylcobalamin or methylcobalamin.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2018
From: PANNEREC, ALICE; FEIGE, JEROME
To: NESTEC S.A.,
Reel/Frame 046231/0858 →
Priority Claims (2)
EP 15202017 · Dec 22, 2015 · regional
EP 16180946 · Jul 25, 2016 · regional
Continuity (1)
Related Publication 20180353534A1 · Dec 13, 2018